Navigation Links
Testosterone Therapy can improve sexual function in postmenopausal women

The addition of testosterone to hormone therapy in women after menopause has been found to enhance their sexual performance. However, it may also reduce HDL cholesterol (the “good” cholesterol) in women, according to a recent research.//

Menopause generally begins around age 40, and is characterized by decreased levels of the female sex hormones- estrogen and progesterone that preserve intactness of the vagina and uterus. In addition the hormone is also involved in the health of bones and keeping HDL at healthy levels. Changes brought by menopause can lead to side effects such as “hot flashes” and problems with mood, sleep, memory and joint stiffness.

Sexual function is also compromised in many women. The genital area can become dry and thin during or after menopause, making sexual intercourse painful and undesirable. There is an accompanying decrease in the sex drive (libido), reflected by slower sexual response in some women.

Testosterone is a natural sex hormone produced by the testis. Although it is thought of as a male hormone, women secrete small amounts of it as well. The present study involved the examination of over 1,957 patients who were given testosterone in addition to the conventional hormone replacement therapy for 6 months. The participants were required to fill questionnaires reflecting their sexual activity, libido and side effects if any.

The observed benefits and side effects included a sense of well-being, unexplained fatigue, breast cancer, mood changes, acne and increased hair growth; none were significant enough to be linked definitively to the addition of testosterone to hormone replacement therapy. If the reduction in HDL had been associated with an increase in triglycerides [fatty acids] or LDL cholesterol it would be of great concern. Testosterone has not been found to alter other coronary heart disease risk factors. The researchers have however expressed concern for potential side effects with long term testosterone usage such as voice changes, increased body and facial hair, acne and other undesirable defeminizing side-effects.

The authors do caution that adding testosterone to HT is not a panacea for sexual dysfunction in women and that a comprehensive approach is recommended. “Because of the complex nature of female sexual dysfunction it is often difficult to establish the meaningful steps in treatment,” they write. “Treatment options for sexual dysfunction include identification of correctable causes, education and counseling, and medical therpy.”
'"/>




Related medicine news :

1. Testosterone Replacement Therapy Safe If Monitored Appropriately
2. Low Testosterone Levels the Cause Of Depression In Men
3. The Use Of Testosterone Replacement Therapy Questioned
4. Depression In Men Could Be To Low Testosterone Levels
5. Testosterone patch for women Rejected For safety Reasons
6. Testosterone Patches Found To Increase Sexual Desire In Menopausal Women
7. Fatherhood Found To Tame Men by Reducing Testosterone Levels
8. Testosterone levels could serve as a marker for determining risk of SIDS
9. Males Lifespan Shortened By Elevated Levels Of Testosterone
10. Study Indicates An Increased Risk Of Breast Cancer In Women Undertaking Estrogen and Testosterone Therapy
11. Low Testosterone Linked With Early Death
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/28/2017)... CARTERSVILLE, Georgia (PRWEB) , ... March 28, 2017 ... ... analyst to its award-winning team. Ruel Williamson brings his extensive knowledge of appraisals, ... been a leader in the real estate valuation industry for more than 40 ...
(Date:3/28/2017)... ... March 29, 2017 , ... Dr. Isabella Wentz, PharmD, FASCP, one ... video series titled The Thyroid Secret. Dr. Wentz talked about journey and research recently ... fact that medication IS NOT the only solution to deal with thyroid disease. ...
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... ... and by physicians, announced today the launch of a free, public-facing tool for ... Cost Analyzer (VCA) was developed to provide comparative information to patients, providers, insurers ...
(Date:3/28/2017)... , ... March 28, 2017 , ... Usually, the impending ... daily wardrobe. However, for those self-conscious about a double chin, this means more anxiety ... ideal solution. , “For most people, a double chin is undesirable,” Dr. Goldman ...
(Date:3/28/2017)... ... March 28, 2017 , ... Qualidigm , the ... headquarters to a new, more expansive office space in order to accommodate its ... a distressed office building in Wethersfield, Conn. located at 936 Silas Deane Highway ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... REDWOOD CITY, Calif. , March 28, 2017 ... pharmaceutical company focused on the development and commercialization ... acute pain, announced that the European Medicines Agency ... (sufentanil sublingual tablet, 30 mcg) Marketing Authorisation Application ... review of the MAA is underway. The MAA ...
(Date:3/28/2017)... , March 28, 2017  Medeon Biodesign, Inc., ... company, is pleased to announce that the Company ... of Panther Orthopedics, Inc., a San ... fixation solutions for orthopedic extremity applications.  ... expand rapidly, primarily due to procedure volume growth, ...
(Date:3/27/2017)... 2017 Therapix Biosciences Ltd. ... in the development of cannabinoid-based drugs, today announced ... the United States of 2,000,000 ... ordinary shares of the Company, at a price ... granted the underwriters a 45-day over-allotment option to ...
Breaking Medicine Technology: